Jie Chen

12PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 23, 2025
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception.

Xinyuan Chen, Shanyue Sun, Shuofeng Li

|Apr 17, 2025
Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases.

Xianlong Chen, Shanyue Sun, Jiapeng Zhao

|Jul 21, 2023
Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma.

Heng Ma, Xianlong Chen, Shengwei Mo

|Mar 23, 2022
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study.

Shuangni Yu, Zezheng Sun, Liju Zong

|Jan 27, 2022
Analysis of a novel immune checkpoint, Siglec-15, in pancreatic ductal adenocarcinoma.

Xianlong Chen, Shengwei Mo, Yue Zhang

|Jan 17, 2022
PD-L1 and PD-L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules.

Yue Zhang, Xianlong Chen, Shengwei Mo

Pageof 2

Frequent Collaborators

9 joint publications

Shuangni Yu

5 joint publications

Liju Zong

4 joint publications

Yang Xiang

4 joint publications

Zhaohui Lu